These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 14529595)

  • 21. Subarachnoid hemorrhage--a rare complication after intravenous thrombolysis in an ischemic stroke patient.
    Chou CL; Lin YJ; Po HL; Chang CK
    Am J Emerg Med; 2010 Oct; 28(8):984.e1-3. PubMed ID: 20825835
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis.
    Wardlaw JM; Sandercock PA; Berge E
    Stroke; 2003 Jun; 34(6):1437-42. PubMed ID: 12730560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolysis in acute ischemic stroke.
    Lang W; Domanovits H; Görzer H; Germann P; Gatterbauer E; Segall B
    Acta Anaesthesiol Scand Suppl; 1997; 111():34-7. PubMed ID: 9420947
    [No Abstract]   [Full Text] [Related]  

  • 25. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 27. Hazards of thrombolytic therapy for stroke: the real-world experience.
    Hurley JC
    Intern Med J; 2007 May; 37(5):348-9; author reply 349-50. PubMed ID: 17504292
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies.
    Külkens S; Hacke W
    Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
    Hoffman JR
    Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
    [No Abstract]   [Full Text] [Related]  

  • 30. Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke.
    Schmülling S; Rudolf J; Strotmann-Tack T; Grond M; Schneweis S; Sobesky J; Thiel A; Heiss WD
    Cerebrovasc Dis; 2003; 16(3):183-90. PubMed ID: 12865603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 32. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA; Lew R; Zivin JA
    Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EMS mythology. EMS myth #2. Thombolytic therapy is the standard of care for acute ischemic stroke.
    Bledsoe BE
    Emerg Med Serv; 2003 Apr; 32(4):63-5. PubMed ID: 12705219
    [No Abstract]   [Full Text] [Related]  

  • 34. Does dementia increase risk of thrombolysis?: a case-control study.
    Alshekhlee A; Li CC; Chuang SY; Vora N; Edgell RC; Kitchener JM; Kale SP; Feen E; Piriyawat P; Callison RC; Cruz-Flores S
    Neurology; 2011 May; 76(18):1575-80. PubMed ID: 21451151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is asymptomatic hemorrhagic transformation really innocuous?
    Park JH; Ko Y; Kim WJ; Jang MS; Yang MH; Han MK; Oh CW; Park SH; Lee J; Lee J; Bae HJ; Gorelick PB
    Neurology; 2012 Feb; 78(6):421-6. PubMed ID: 22282643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
    Kandzari DE; Granger CB; Simoons ML; White HD; Simes J; Mahaffey KW; Gore J; Weaver WD; Longstreth WT; Stebbins A; Lee KL; Califf RM; Topol EJ;
    Am J Cardiol; 2004 Feb; 93(4):458-61. PubMed ID: 14969623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolysis in dementia patients with acute stroke: is it justified?
    Paciaroni M; Pantoni L
    Neurol Sci; 2017 Jan; 38(1):27-31. PubMed ID: 27699498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke.
    Putaala J; Sairanen T; Meretoja A; Lindsberg PJ; Tiainen M; Liebkind R; Strbian D; Atula S; Artto V; Rantanen K; Silvonen P; Piironen K; Curtze S; Häppölä O; Mustanoja S; Pitkäniemi J; Salonen O; Silvennoinen H; Soinne L; Kuisma M; Tatlisumak T; Kaste M
    Cerebrovasc Dis; 2011; 31(1):83-92. PubMed ID: 21079397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous thrombolysis for acute ischemic stroke.
    Tomsick TA
    J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 2):S67-76. PubMed ID: 15106579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.